Top compounds associated with response to CTD-2006C1.13


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.03
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC 0.13 0.03
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.078 0.03
mRNA neratinib CTRPv2 pan-cancer AAC 0.084 0.03
mRNA lomeguatrib CTRPv2 pan-cancer AAC 0.088 0.03
mRNA hyperforin CTRPv2 pan-cancer AAC -0.092 0.03
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.03
mRNA AZ-3146 CTRPv2 pan-cancer AAC 0.082 0.03
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.04
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.04
Download CSV